Effect and mechanism of panaxoside Rg1 on neovascularization in myocardial infarction rats

Chinese Journal of Integrative Medicine

Volumn 16, Issue 2, 2010, Pages 162-166

  Wang, Xiao Dong ^a   Gu, Tian Xiang ^a   Shi, En Yi ^a   Lu, Chun Mao ^a   Wang, Chun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Collateral circulation; Ginsenoside Rg1; mTOR protein; Myocardial infarction; Signal transduction

Indexed keywords

CD31 ANTIGEN; GINSENOSIDE RB 1; HEART ENZYME; HYPOXIA INDUCIBLE FACTOR 1ALPHA; RAPAMYCIN;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DENSITY; DRUG EFFECT; DRUG INDUCED DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIGENS, CD31; CELL COUNT; COLLATERAL CIRCULATION; DRUG EVALUATION, PRECLINICAL; GINSENOSIDES; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICROVESSELS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PLACEBOS; PROTEIN-SERINE-THREONINE KINASES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SIROLIMUS;

EID: 77954475152     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-010-0162-4     Document Type: Article

References (20)

1. Yang M, Chen GL, Chen C, Zhang Y, Yan CY. Therapeutic effects of ginsenoside Rg1 on rats with myocardial infarction. Chin J Integr Med Cardio/cerebrovasc Dis (Chin) 2007; 5:1075-1077.
2. Jin Y, Liu GN. Effects of ginsenoside Rg1 on angiogenesis and VEGF expression in rats with acute myocardial infarction. J China Med Univ (Chin) 2007;36:517-519.
3. Hidekazu S, Tatsuya S, Kyoko H, Sachiko S, Joseph Y, Masayuki Y, et al. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 2008; 118:S145-S152.
4. Lei L, Zhou R, Zheng W, Christensec LP, Weiss RM, Tomanek RJ. Bradycardia induces angiogenesis, increases coronary reserve, and preserves function of the postinfarcted Heart. Circulation 2004;110:796-802.
5. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9-19.
6. Hsieh PC, MacGillivray C, Gannon J, Cruz FU, Lee RT. Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity. Circulation 2006;114:637-644.
7. Radad K, Gille G, Moldzio R, Saito H, Rausch WD. Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res 2004;1021:41-53.
8. Min JK, Kim JH, Cho YL. 20(S)-ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. Biochem Biophys Res Commun 2006;349:987-994.
9. Niu YP, Qiao XD, Wang WX. Effect of panaxadiol saponin and panaxtrol saponin on proliferation of human bone marrow hemopoietic progenitor cells. Chin J Integr Tradit West Med (Chin) 2004;24:127-129,132.
10. Shen LH, Zhang JT. Culture of neural stem cells from cerebral cortex of rat embryo and effects of drugs on the proliferation ability of stem cells. Acta Pharm Sin (Chin) 2003; 38:735-738.
11. Zeng XL, Tu ZG. In vitro induction of differentiation by ginsenoside Rh2 in SMMC-7721 hepatocarcinoma cell line. Pharmacol Toxicol 2003;93:275-283.
12. Chan RY, Chen WF, Dong A, Guo D, Wong MS. Estrogen-like activity of ginsenoside-Rg1 derived from Panax notoginseng. J Clin Endocrinol Metab 2002;87:3691-3695.
13. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, et al. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995; 91:755-763.
14. Yu LC, Chen WC, Huang YC, Huang YC, Lin KM, Lai PH, et al. Stability of angiogenic agents, ginsenoside Rg1 and Re, isolated from Panax ginseng: in vitro and in vivo studies. Int J Pharm 2007; 328:168-176.
15. Li HJ, Fan JM. Pharmacologic action and mechanisms of panaxoside Rg1. Sichuan Med (Chin) 2006; 27:1007-1008.
16. Nissim H, Nahum S. Upstream and downstream of mTOR. Gene Dev 2004; 18:1926-1945.
17. Bernardi R, Guernah I, Jin D, Grisendi S, Alimonti A, Teruya-Feldstein J, et al. PML inhibits HIF-1 alpha translation and neoangiogenesis through repression of mTOR. Nature 2006; 442:779-785.
18. Land SC, Tee AR. Hypoxia-inducible factor 1 alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 2007; 282:20534-20543.
19. Licht AH, Flamme I, Breier G, Muller-Holtkamp F. Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development. Blood 2006;107:584-590.
20. Jun HO, Kim Y, Kwon YW, HongSS, Kim KW, Shin J, et al. Wondonin, a novel compound, inhibits hypoxia-induced angiogenesis through hypoxia-inducible factor-1 alpha. FEBS Lett 2007;581:4977-4982.